Josh Wolfe

Co-founder and Managing Partner
Helps lead firm. Invests in defense, biotech, and co-founds companies.

About Josh

Josh co-founded Lux Capital to support scientists and entrepreneurs who pursue counter-conventional solutions to the most vexing puzzles of our time in order to lead us into a brighter future. The more ambitious the project, the better—like, say, creating matter from light.

Josh is a Director at Aera Therapeutics, Cajal Neuroscience, Eikon Therapeutics, Impulse Labs, Kallyope, Osmo, Variant Bio, and helped lead the firm’s investments in Anduril, Echodyne, Planet, Hadrian, Osmo and Resilience. He is a founding investor and board member with Bill Gates in Kymeta, making cutting-edge antennas for high-speed global satellite and space communications. Josh is a Westinghouse semi-finalist and published scientist. He previously worked in investment banking at Salomon Smith Barney and in capital markets at Merrill Lynch. In 2008 Josh co-founded and funded Kurion, a contrarian bet in the unlikely business of using advanced robotics and state-of-the-art engineering and chemistry to clean up nuclear waste. It was an unmet, inevitable need with no solution in sight. The company was among the first responders to the Fukushima Daiichi disaster. In February 2016, Veolia acquired Kurion for nearly $400 million—34 times Lux’s total investment.

Avoid boring people. –Jim Watson

Josh is a columnist with Forbes and Editor for the Forbes/Wolfe Emerging Tech Report. He has been invited to The White House and Capitol Hill to advise on nanotechnology and emerging technologies, and a lecturer at MIT, Harvard, Yale, Cornell, Columbia and NYU. He is a term member at The Council on Foreign Relations, a Trustee at the Santa Fe Institute, and Chairman of Coney Island Prep charter school, where he grew up in Brooklyn. He graduated from Cornell University with a B.S. in Economics and Finance.

Ea velit est reprehenderit qui officia nostrud exercitation nisi. Anim pariatur ea voluptate occaecat laborum. Culpa qui sint labore eu aute ut ut. Proident eu ullamco aute commodo qui enim ut. Consectetur esse laborum enim.

Fugiat pariatur quis eu. Esse culpa consequat quis. Qui irure anim nulla deserunt ut est Lorem excepteur dolore occaecat eiusmod velit magna cupidatat. Ex id tempor ea mollit velit aute ex eiusmod sint id incididunt.

Ut aliqua in laborum pariatur deserunt incididunt id labore incididunt do consectetur. Lorem Lorem quis voluptate. Duis cillum non mollit nostrud dolor ullamco consequat qui pariatur. Anim quis ut minim consequat non occaecat tempor esse aliqua anim in. Consequat anim consectetur elit labore minim laborum voluptate. Ad eu laborum enim pariatur tempor nostrud Lorem veniam. Do do officia id. Magna ipsum ad veniam et laboris minim pariatur est laboris ad labore.
“The future is already here... it's just not evenly distributed yet.” — William Gibson
Outside of work
Aute quis proident ad eu.
Aute quis proident ad eu.Elit ut non est consequat eu aute officia est. Voluptate laboris occaecat quis qui nulla elit cillum mollit anim ut aute aliquip consequat officia. Labore qui ad nulla sit tempor qui adipisicing aliquip officia labore enim do. Ullamco fugiat exercitation minim occaecat duis elit deserunt nulla esse do eu enim commodo. Aliquip aliqua officia ex reprehenderit amet magna exercitation consequat excepteur cupidatat sint enim labore. Ut ipsum ut veniam consequat velit irure anim veniam fugiat irure sunt do in.

Selected Investments

aera-cover-image
Aera Therapeutics
7
josh-wolfe
anduril-cover-image
Anduril
3
josh-wolfe,brandon-reeves
cajal-neuroscience-cover-image
Cajal Neuroscience
24
josh-wolfe,ian-peikon
eikon-therapeutics-cover-image
Eikon Therapeutics
2
josh-wolfe
hadrian-cover-image
Hadrian
12
josh-wolfe,brandon-reeves
kallyope-cover-image
Kallyope
5
josh-wolfe
kurion-cover-image
Kurion
9999
josh-wolfe
osmo-cover-image
Osmo
8
josh-wolfe

other team members

Peter Hébert
Co-founder and Managing Partner
Investing
Shahin Farshchi, PhD
General Partner
Investing
Brandon Reeves
General Partner
Investing
Deena Shakir
General Partner
Investing
Bilal Zuberi
General Partner
Investing
Grace Isford
Partner
Investing
Tess van Stekelenburg
Science Partner
Investing
Shaq Vayda
Principal
Investing
Lan Jiang
Associate
Investing
Adam Kalish
General Partner
Development and Operations
Steven Brody
Chief Operating Officer
Development and Operations
Scott Rubin
Chief Marketing Officer
Development and Operations
Segolene Scarborough
Chief Financial Officer
Development and Operations
Sean Traynor
General Counsel
Development and Operations
Alex Nguyen
Partner
Development and Operations
Danny Crichton
Head of Editorial
Development and Operations
Tracie Rotter
Platform Partner
Development and Operations
Saunaz Moradi
Director of Communications
Development and Operations
Samuel Arbesman, PhD
Scientist in Residence
Development and Operations
Andrew Wilson
Associate General Counsel
Development and Operations
Samantha Cho
VP of Finance
Development and Operations
Stevie Lee
Assistant Controller
Development and Operations
Brad Gritsch
Accounting Manager
Development and Operations
Kim Tran
Fund Accountant
Development and Operations
Bibi Masara
Office Manager
Development and Operations
Debbie Elsen
Executive Assistant
Development and Operations
Jasmine Rainey
Executive Assistant and Marketing Coordinator
Development and Operations
Lindsay Morris
Executive Assistant
Development and Operations
Cristina Morris
Executive Assistant
Development and Operations
Bree Morgan
Executive Assistant
Development and Operations
Kim Tran
Tess van Stekelenburg
Andrew Wilson
Jasmine Rainey
Tracie Rotter
Stevie Lee
Steven Brody
Shaq Vayda
Shahin Farshchi, PhD
Segolene Scarborough
Sean Traynor
Scott Rubin
Saunaz Moradi
Samuel Arbesman, PhD
Samantha Cho
Peter Hébert
Lindsay Morris
Lan Jiang
Josh Wolfe
Grace Isford
Deena Shakir
Debbie Elsen
Danny Crichton
Cristina Morris
Bree Morgan
Brandon Reeves
Brad Gritsch
Bilal Zuberi
Bibi Masara
Alex Nguyen
Adam Kalish